Holding(s) in Company

Summary by AI BETAClose X

UBS AG has acquired a significant stake in Renalytix PLC, now holding 5.171089% of the voting rights, which equates to 22,598,626 shares. This acquisition crossed the notification threshold on May 1, 2026, and was reported to the issuer on May 4, 2026. The notification indicates an acquisition of voting rights, with UBS AG's position previously being zero. There are no financial instruments with similar economic effects or other financial instruments that would alter this holding.

Disclaimer*

UK 100

Latest directors dealings